Efficacy of a Microencapsulated Sugar‐Free Probiotic Oral Rinse on Gingival Health and Salivary Matrix Metalloproteinases 8 and 9 in Children With Down Syndrome: A Pilot Randomized Clinical Trial
Special Care in Dentistry · 2026
DOI: 10.1111/scd.70213 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Special Care in Dentistry, 2026. Verfasst von Swagata Saha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pedodontics and Preventive Dentistry, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), …. Hauptthemen laut MEDLINE: Probiotics, Matrix Metalloproteinase 8, Matrix Metalloproteinase 9, Mouthwashes. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NITTE.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Children with Down Syndrome (DS) are at heightened risk for oral diseases due to their distinct physiological and immune characteristics. Matrix metalloproteinases (MMPs), particularly MMP‐8 and MMP‐9, are key mediators of periodontal tissue breakdown. Probiotics may provide a novel, well‐tolerated alternative to conventional antiseptics by modulating these biomarkers.
Methods
This single‐center, parallel‐arm, randomized, single‐blind pilot trial compared a sugar‐free microencapsulated probiotic oral rinse against a 0.2% chlorhexidine digluconate rinse in children with DS. A total of 118 participants aged 6–14 years were enrolled; following attrition after oral rehabilitation, 40 children (20 per group) were allocated to intervention, and 15 participants per group completed all assessments. After individualized oral rehabilitation and oral health education, participants were randomized (1:1). Group 1 received probiotic rinse and Group 2 chlorhexidine rinse, both administered twice daily for two weeks. Primary outcomes were salivary MMP‐8 and MMP‐9 levels (enzyme‐linked immunosorbent assay). Secondary outcomes were plaque index (PI), gingival index (GI), oral hygiene index–simplified (OHI‐S), and bleeding on probing (BOP). Outcomes were assessed at baseline prior to oral rehabilitation (T0), two weeks after completion of oral rehabilitation (T1), two weeks following completion of the rinse protocol (T2), and six months post‐rinse (washout period, T3) by blinded examiners.
Results
All 30 randomized participants completed the trial (15 per group). Both groups showed significant within‐group reductions in MMP‐8, MMP‐9, PI, GI, OHI‐S, and BOP at follow‐up ( p < 0.05). Between‐group comparisons showed no significant differences in MMP levels, PI, GI or OHI‐S at any interval. At six months, the probiotic group demonstrated a greater reduction in BOP compared with chlorhexidine (median difference –6.0; 95% CI [–9.0, –3.0]; p = 0.001). Given the two‐week duration of rinsing, this isolated 6‐month difference should be interpreted cautiously. Harms No systemic side effects or gastrointestinal symptoms were reported. Mild tooth staining occurred in two participants in the chlorhexidine group; no adverse effects were reported in the probiotic group.
Conclusion
Both rinses demonstrated within‐group improvements, although no significant between‐group differences were observed in the primary biochemical outcomes. The probiotic rinse showed comparable short‐term efficacy and better tolerability, but due to underpowering and design limitations, findings remain exploratory. Larger, adequately powered studies are required to determine true clinical effectiveness. Trial Registration This study was a registered clinical trial with the Clinical Trials Registry of India (CTRI/2023/04/051447). The trial was prospectively registered, adhering to the WHO standards for clinical trial registration to ensure transparency and integrity in reporting health‐related outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pedodontics and Preventive Dentistry, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, Maharashtra, India.
- Department of Pediatric and Preventive Dentistry, A B Shetty Memorial Institute of Dental Sciences, NITTE (Deemed to be University), Mangaluru, Karnataka, India.
- Department of Biochemistry, K S Hegde Medical Academy (KSHEMA), NITTE (Deemed to be University), Mangaluru, Karnataka, India.
- Central Research Laboratory KSHEMA, NITTE (Deemed to be University), Mangaluru, Karnataka, India.
- K S Hegde Medical Academy (KSHEMA), NITTE (Deemed to be University), Mangaluru, Karnataka, India.
ORCID-Profile: Swagata Saha, Manju Raman Nair, Kavita Rai, Prajna P Nayak, Suchetha Kumari N, Prajna Bhandary, Sharmila K P, Neevan D'souza
Förderung
- NITTE
Zitieren
APA
Saha, S., Nair, M. R., Rai, K., Nayak, P. P., N, S. K., Bhandary, P., K P, S., & D'souza, N. (2026). Efficacy of a Microencapsulated Sugar‐Free Probiotic Oral Rinse on Gingival Health and Salivary Matrix Metalloproteinases 8 and 9 in Children With Down Syndrome: A Pilot Randomized Clinical Trial. Special Care in Dentistry. https://doi.org/10.1111/scd.70213
Vancouver
Saha S, Nair MR, Rai K, Nayak PP, N SK, Bhandary P, et al. Efficacy of a Microencapsulated Sugar‐Free Probiotic Oral Rinse on Gingival Health and Salivary Matrix Metalloproteinases 8 and 9 in Children With Down Syndrome: A Pilot Randomized Clinical Trial. Special Care in Dentistry. 2026. doi:10.1111/scd.70213
BibTeX
@article{Saha2026,
author = {Saha, Swagata and Nair, Manju Raman and Rai, Kavita and Nayak, Prajna P and N, Suchetha Kumari and Bhandary, Prajna and K P, Sharmila and D'souza, Neevan},
title = {Efficacy of a Microencapsulated Sugar‐Free Probiotic Oral Rinse on Gingival Health and Salivary Matrix Metalloproteinases 8 and 9 in Children With Down Syndrome: A Pilot Randomized Clinical Trial},
journal = {Special Care in Dentistry},
year = {2026},
doi = {10.1111/scd.70213}
}
EUVIMED